MedPath

Myorelaxant Effect of Cannabis Cream Topical Skin Application in Patients With TMD

Phase 2
Completed
Conditions
Electromyography
Temporomandibular Disorder
Myofascial Pain
Cannabis
Interventions
Combination Product: Cannabis Cream
Combination Product: Placebo Cream
Registration Number
NCT03994640
Lead Sponsor
Medical University of Silesia
Brief Summary

Evaluation of myorelaxant effect of cannabis cream.compared to placebo cream in topical skin application in patients with TMD

Detailed Description

Cannabis sativa has a very wide application in various fields of medicine. In patients with temporomandibular disorder, especially with myofascial pain of masticatory muscles there is a special need to seek an effective pain therapy and muscle relaxing methods. Patients with TMD suffer from chronic pain and depression, cannabis topical skin application therapy seems promising in that field. Patients attending The Department of TMD in Zabrze, Polska were randomly divided into two groups: experimental and placebo. sEMG activity values were compared during 14 days therapy with cream. Positive results were obtained confirming the efficacy of the cannabis cream used in the study, compared to placebo.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cannabis creamCannabis CreamCannabis cream topical skin application in experimental group
Placebo creamPlacebo CreamPlacebo cream topical skin application in control group
Primary Outcome Measures
NameTimeMethod
Reduction of sEMG activity of masseter muscle14 days

Reduction in masseter muscle electromyographic activity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of TMD Silesian Medical University

🇵🇱

Zabrze, Poland

© Copyright 2025. All Rights Reserved by MedPath